Gene Diagnosis and Prognostic Significance of Lymph Node Micrometastasis after Complete Resection of Histologically Node-negative Non-small Cell Lung Cancer

Shu-Hai Li; Zhou Wang; Xiang-Yan Liu; Fan-Ying Liu
August 2008
World Journal of Surgery;Aug2008, Vol. 32 Issue 8, p1651
Academic Journal
The purpose of the present study was to investigate the prevalence of lymph node micrometastasis (LNMM) based on the detection of MUC1 mRNA, and assess the impact of these micrometastases on prognosis after resection of pathologic N0 (pN0) non-small cell lung cancer (NSCLC). The subjects were 89 patients who underwent complete resection of pN0 NSCLC at our department between January 2000 and January 2002. All lymph nodes (402 stations) obtained from these patients were re-evaluated by reverse transcriptase-polymerase chain reaction (RT-PCR) to detect MUC1 mRNA. The diagnosis of LNMM was based on the detection of MUC1 mRNA. The Kaplan-Meier method was used to calculate the survival rate, and Cox regression multivariate analysis was performed to determine independent prognostic factors. Micrometastases were detected in 36 lymph node stations (9.0%) from 21 patients (23.6%). The TNM staging of these 21 patients was upregulated from stage IA–IIB to stage IIIA. The 5-year survival rate of patients with LNMM was significantly lower than that of patients without LNMM (23.8% versus 44.1%; p < 0.05). The results of multivariate analysis confirmed that T status, histology, and LNMM were independent prognostic factors. The prevalence of LNMM in patients with pN0 NSCLC was 23.6% (21/89). T status, histology, and LNMM were independent prognostic factors.


Related Articles

  • Lymphatic Vessel Density Is Not Associated With Lymph Node Metastasis in Non--Small Cell Lung Carcinoma. Faoro, Leonardo; Hutto, Joann Y.; Salgia, Ravi; El-Zayaty, Shady A.; Ferguson, Mark K.; Cheney, Richard T.; Reid, Mary E.; Armato III, Samuel G.; Krausz, Thomas; Husain, Aliya N. // Archives of Pathology & Laboratory Medicine;Dec2008, Vol. 132 Issue 12, p1882 

    Context.--Angiogenesis is essential for tumors to grow and metastasize. Lymphatic metastasis is also an important means of tumor spread. In non-small cell lung carcinoma, the relationship of lymphangiogenesis with lymph node metastasis and, ultimately, patient prognosis is unknown....

  • Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases Casali, Christian; Stefani, Alessandro; Natali, Pamela; Rossi, Giulio; Morandi, Uliano // European Journal of Cardio-Thoracic Surgery;Jul2005, Vol. 28 Issue 1, p33 

    Abstract: Objective: Patients with non-small cell lung cancer (NSCLC) with metastases to ipsilateral mediastinal lymph nodes (N2) are an heterogeneous group of patients as regard to prognosis and treatment. Indication and timing of surgery remain controversial. The present study investigates the...

  • BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification. Ben-yuan Jiang; Xu-chao Zhang; Jian Su; Wei Meng; Xue-ning Yang; Jin-ji Yang; Qing Zhou; Zhi-yong Chen; Zhi-hong Chen; Zhi Xie; Shi-liang Chen; Yi-long Wu // Molecular Cancer;2013, Vol. 12 Issue 1, p1 

    Background: Aberrant activation of the proto-oncogene B-cell lymphoma/leukemia 11A (BCL11A) has been implicated in the pathogenesis of leukemia and lymphoma. However, the clinical significance of BCL11A in non-small cell lung cancer (NSCLC) remains unknown. Results: We examined BCL11A expression...

  • Endoscopic ultrasound: a useful tool to assess the mediastinum in patients with lung cancer? Penman, I.; Fergusson, R. J. // Thorax;Feb2002, Vol. 57 Issue 2, p95 

    Mediastinal involvement either by direct invasion or by spread to lymph nodes is seen at diagnosis in up to 50% of patients with non-small cell lung cancer and has a significant impact on both treatment and prognosis. Ipsilateral or subcarinal lymph node involvement is associated with a 5 year...

  • Value of the Metastatic Lymph Node Ratio for Predicting the Prognosis of Non-Small-Cell Lung Cancer Patients. Wang, Chang-Li; Li, Yue; Yue, Dong-Sheng; Zhang, Lian-Min; Zhang, Zhen-Fa; Sun, Bing-Sheng // World Journal of Surgery;Feb2012, Vol. 36 Issue 2, p455 

    Background: The aim of this study was to investigate the relation between the metastatic lymph node ratio (LNR) and the prognosis of non-small-cell lung cancer (NSCLC). Methods: A total of 301 patients with N1 or N2 NSCLC who underwent complete pulmonary resection were analyzed retrospectively....

  • Chimiothérapie pré-opératoire des cancers bronchiques non à petites cellules. Moro-Sibilot, D.; Diab, S.; Fourneret, P.; Aubert, A. // Oncologie;oct2005, Vol. 7 Issue 6, p451 

    The five-year survival rates for patients with non-small cell lung cancer (NSCLC) ranges from 9 to 61% following resection, depending on clinical stage; survival rates post-surgery (pathologic stage) range from 25 to 67%. Surgical resection remains the standard of care in early stage NSCLC,...

  • BRCA1 and ERCC1 mRNA levels are associated with lymph node metastasis in Chinese patients with colorectal cancer. Lu Yuanming; Zhang Lineng; Song Baorong; Peng Junjie; Cai Sanjun // BMC Cancer;2013, Vol. 13 Issue 1, p1 

    Background: Although both excision repair cross-complementing group 1 (ERCC1) and breast cancer susceptibility gene 1 (BRCA1) can be effective biomarkers for chemosensitivity in primary malignant tumors, their applicability to metastases is poorly understood. Here, ERCC1 and BRCA1, which are...

  • Morphometric analysis of regional lymph nodes in surgically resected non-small cell lung cancer. Gotoh, Hajimu; Kanomata, Naoki; Yoshimura, Masahiro; Ohno, Yoshiharu; Moriya, Takuya; Ohbayashi, Chiho // Medical Molecular Morphology;Sep2009, Vol. 42 Issue 3, p162 

    Nodal staging is a crucial factor in choosing the treatment option for non-small cell lung cancer (NSCLC). However, so far as we know, a computer-based histomorphometric analysis of lymph nodes in NSCLC has never been developed. We studied 299 surgically resected lymph nodes from 108 patients...

  • Prognosis associated with surgery for non-small cell lung cancer and synchronous brain metastasis. Kanou, Takashi; Okami, Jiro; Tokunaga, Toshiteru; Fujiwara, Ayako; Ishida, Daisuke; Kuno, Hidenori; Higashiyama, Masahiko // Surgery Today;Jul2014, Vol. 44 Issue 7, p1321 

    Purpose: Several reports have described extended survival after aggressive surgical treatment for non-small cell lung cancer (NSCLC) and synchronous brain metastasis. This retrospective analysis assesses the prognostic factors in this population. Methods: We reviewed retrospectively the medical...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics